Basecamp Research

Basecamp Research is a Therapeutics startup based in London, United Kingdom that has raised $225M in venture capital across 1 funding round since 2019. The company reached Series C stage in September 2026 with a $140M round led by S32 at a $800M valuation. Basecamp Research's investor base includes 7 institutional funds, with S32 leading the most recent equity round.

Basecamp Research is a London-based AI biotech company that designs programmable therapeutics by combining frontier foundation models with the world's largest proprietary evolutionary genomic dataset. Founded in 2019 by synthetic biologist Dr. Glen Gowers and biomedical engineer Dr. Oliver Vince, the company built the Trillion Gene Atlas — a database of genomic sequences collected through biodiversity partnerships across more than 30 countries — and used it to train EDEN, a family of multi-modal foundation models capable of designing across biological modalities from programmable gene insertion to synthetic microbiomes. The company's primary clinical program targets in vivo cell therapy, a modality that reprograms a patient's own cells inside the body rather than manufacturing them externally. This approach eliminates the complex and costly ex vivo manufacturing step that limits access to current cell and gene therapies. Basecamp has built a preclinical pipeline of six therapy programs, each designed directly from its AI models, covering conditions where the biology is well-understood but therapeutic tools have not yet caught up. In September 2026, Basecamp Research closed a $140 million oversubscribed Series C led by S32, with participation from NVIDIA, Anthropic's Anthology Fund, Catalio Capital Management, NATO Innovation Fund, The Rockefeller Foundation, and True Ventures, among others. The round values the company at $800 million and brings total funding to approximately $225 million. The capital will fund the transition of preclinical programs toward clinical-stage development and expand the company's team across its London and Cambridge, Massachusetts offices.

Lead investors

Co-investors

• FundingBasecamp Research Raises $140 Million Series C Led By S32 To Advance AI-Designed TherapeuticsSeptember 2026